Axa’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-31,300
| Closed | -$670K | – | 1091 |
|
|
2023
Q2 | $670K | Buy |
+31,300
| New | +$670K | ﹤0.01% | 908 |
|
|
2023
Q1 | – | Sell |
-6,200
| Closed | -$288K | – | 1127 |
|
|
2022
Q4 | $288K | Hold |
6,200
| – | – | ﹤0.01% | 1055 |
|
|
2022
Q3 | $322K | Buy |
+6,200
| New | +$322K | ﹤0.01% | 1026 |
|
|
2021
Q3 | – | Sell |
-62,400
| Closed | -$2.75M | – | 1251 |
|
|
2021
Q2 | $2.75M | Buy |
62,400
+23,253
| +59% | +$1.02M | 0.01% | 828 |
|
|
2021
Q1 | $1.93M | Buy |
39,147
+31,047
| +383% | +$1.53M | 0.01% | 855 |
|
|
2020
Q4 | $341K | Buy |
8,100
+300
| +4% | +$12.6K | ﹤0.01% | 1123 |
|
|
2020
Q3 | $357K | Hold |
7,800
| – | – | ﹤0.01% | 1093 |
|
|
2020
Q2 | $392K | Buy |
+7,800
| New | +$392K | ﹤0.01% | 1095 |
|
|
2019
Q1 | – | Sell |
-3,300
| Closed | -$234K | – | 1331 |
|
|
2018
Q4 | $234K | Sell |
3,300
-12,000
| -78% | -$851K | ﹤0.01% | 1208 |
|
|
2018
Q3 | $1.31M | Sell |
15,300
-2,100
| -12% | -$180K | ﹤0.01% | 976 |
|
|
2018
Q2 | $2.02M | Buy |
+17,400
| New | +$2.02M | 0.01% | 850 |
|
|
2015
Q4 | – | Sell |
-36,590
| Closed | -$1.32M | – | 1421 |
|
|
2015
Q3 | $1.32M | Buy |
+36,590
| New | +$1.32M | 0.01% | 859 |
|
|
2015
Q2 | – | Sell |
-30,350
| Closed | -$929K | – | 1421 |
|
|
2015
Q1 | $929K | Buy |
30,350
+550
| +2% | +$16.8K | ﹤0.01% | 969 |
|
|
2014
Q4 | $1.52M | Buy |
29,800
+17,500
| +142% | +$890K | 0.01% | 864 |
|
|
2014
Q3 | $487K | Buy |
+12,300
| New | +$487K | ﹤0.01% | 1074 |
|